Puede usar las teclas derecha/izquierda para votar el artículo.Votación:1 estrella2 estrellas3 estrellas4 estrellas5 estrellas (1 votos, promedio: 5.00 sobre 5)
LoadingLoading...

Health

Oxford works to have COVID-19 vaccine available in September

London / “No one can set deadlines … things could go wrong, but the reality is that by working with a large pharmaceutical company, that vaccine could be quite available in September and that is the type of objective that is being worked on,” he said David Carpenter, chairman of the Berkshire Research Ethics Committee, which approved the Oxford trial.

Human trials of the candidate vaccine against COVID-19 developed by the University of Oxford have shown “promising results” in having stimulated the desired response of the immune system, as revealed by the UK press on Thursday.

In the human study phase, which began in April and involving about 1,000 healthy volunteers, scientists have detected that the possible vaccine generates antibodies and T cells that may be adequate to generate an immune response against COVID. -19.

The researchers noted that they have yet to demonstrate that this combined immune response is sufficient to prevent infection, but said the fact that such an effect has been proven is very positive.

The vaccine for September

David Carpenter, chairman of the Berkshire Research Ethics Committee, which approved the Oxford trial and continues to work with this group of scientists, said the team was “absolutely on track” to achieve the vaccine.

“No one can set deadlines … things could go wrong, but the reality is that by working with a large pharmaceutical company, that vaccine could be quite available in September and that is the type of objective that is being worked on,” he said. .

AstraZeneca is the pharmaceutical company with which the prestigious university collaborates to achieve this goal.

The British Minister of Health, Matt Hancock, indicated that the researchers, among whom there is also a team from Imperial College London, are working to achieve the “best scenario” that will make it possible to circulate a vaccine throughout this year, although he admitted This is more likely to happen in 2021.

“We are all working to achieve the best scenario, we are all giving AstraZeneca and the Oxford and Imperial (College London) team all possible support. We are also working on other potential vaccines worldwide, including America, Germany and the Netherlands, ”said Hancock. (July 16, 2020, EFE / PracticaEspañol)

(Automatic translation)

The related video news (June 27, 2020):


Noticias al azar

Multimedia news of Agencia EFE to improve your Spanish. News with text, video, audio and comprehension and vocabulary exercises